Abstract
Introduction Uncontrolled blood sugar levels may result in complications, namely diabetic neuropathy. Diabetic neuropathy is a nerve disorder that causes symptoms of numbness, foot deformity, dry skin, and thickening of the feet. The severity of diabetic neuropathy carries the risk of developing diabetic ulcers and amputation. Early detection of diabetic neuropathy can prevent the risk of diabetic ulcers.
Methods This research studied articles in 6 databases via Scopus, Ebsco, Pubmed, Sage journal, Science Direct, and Springer link with the keywords “screening Neuropathy” AND “Detection Neuropathy” AND “Scoring Neuropathy” AND “Diabetic” published in 2019-2023. This study identified articles based on the English language, variables, and population. This research used PRISMA Flow-Chart 2020 to record the article filtering process.
Results This research identified articles through PRISMA Flow-Chart 2020, obtaining 25 articles that discussed early detection of diabetic neuropathy.
Conclusion Early detection of diabetic neuropathy prevents the occurrence of diabetic neuropathy. The method for early detection of neuropathy is using a neuropathy questionnaire and physical examination. Neuropathy questionnaires are Michigan Neuropathy Screening Instrument (MNSI), Toronto Clinical Neuropathy Score (TCNS), and Diabetic Neuropathy Classification (BDC). Physical examination tools include biotesimeters, vibrations, neurotesimeters, tuning forks, monofilament threads, ultrasonography (USG) results, artificial intelligence (AI), and nomograms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
